StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
SCNX

Scienture Holdings, Inc.

SCNX Nasdaq Pharmaceutical Preparations EDGAR ↗
$0.39
+0.01 +1.31%

Key statistics

from XBRL data in SEC filings
Market cap
$15.7M
Revenue (TTM)
$432K
Net income (TTM)
-$41.9M
EPS (TTM)
$-2.45
P/E ratio
Dividend yield
Free cash flow
-$13.4M
Cash
$6.66M
Total assets
$80.7M
Gross margin
76.8%
52-week range
$0.24 – $2.60

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Director or officer change May 29, 2026 8-K Results of operations (earnings release) May 22, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 8-K Regulation FD disclosure May 5, 2026 8-K Entered a material agreement; Took on a direct financial obligation May 1, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 30, 2026 10-K Fiscal year ended 2025-12-31 Mar 30, 2026 8-K Regulation FD disclosure Nov 18, 2025 8-K Shareholder vote results Nov 14, 2025 8-K Other events Nov 13, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Other events Oct 30, 2025 8-K Entered a material agreement Oct 24, 2025 8-K Delisting notice or listing-rule failure Oct 17, 2025 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation Oct 16, 2025 8-K Amended charter or bylaws Oct 6, 2025 8-K Entered a material agreement Oct 3, 2025 8-K Entered a material agreement Sep 23, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Aug 15, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Entered a material agreement; Regulation FD disclosure Jul 24, 2025 8-K Entered a material agreement Jul 3, 2025 8-K Terminated a material agreement; Delisting notice or listing-rule failure; Director or officer change May 22, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Entered a material agreement; Regulation FD disclosure Apr 11, 2025 10-K Fiscal year ended 2024-12-31 Mar 26, 2025 8-K Entered a material agreement; Regulation FD disclosure Mar 21, 2025 8-K Entered a material agreement; Director or officer change; Shareholder vote results Mar 13, 2025 8-K Entered a material agreement; Regulation FD disclosure Mar 10, 2025 8-K Director or officer change Jan 17, 2025 8-K Delisting notice or listing-rule failure; Regulation FD disclosure; Other events Jan 8, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Regulation FD disclosure Nov 26, 2024 10-Q Quarter ended 2024-09-30 Nov 6, 2024 8-K Other events Oct 11, 2024 8-K Regulation FD disclosure Oct 8, 2024 8-K Amended charter or bylaws; Regulation FD disclosure Sep 24, 2024 10-Q Quarter ended 2024-06-30 Aug 9, 2024 8-K Entered a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Modified rights of security holders; Director or officer change; Amended charter or bylaws; Regulation FD disclosure Jul 31, 2024 8-K Other events Jul 9, 2024 10-Q Quarter ended 2024-03-31 Jun 26, 2024